Skip to main content

Cullinan Therapeutics, Inc.

CGEMNASDAQ
$15.51+0.98 (+6.74%)as of Oct 2, 2026
Legend
Insider buy
Insider sell
Congress buy
Congress sell
Hedge Funds
bought vs sold
Greener markers show more buyers; redder markers show more sellers.
Company share activityNet buybacksNo changeNet dilution
Marker size reflects transaction size.
  • Insider buy
  • Insider sell
  • Congress buy
  • Congress sell
  • Hedge Funds bought vs sold
Share activityNet buybacksNo changeNet dilution

Marker size reflects transaction size. Greener fund markers mean more buyers.

  • Insider Buy
  • Insider Sell
  • Congress Buy
  • Congress Sell
  • Hedge funds bought vs sold
  • BuybackNo changeNet dilution

Cullinan Therapeutics, Inc. price and activity chart data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+169.7%). 0 insider or congressional trades plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding

Largest institutional holders

13F · Q2 2026
Fund% of company heldValue% of portfolioQuarterly activity
MPM Bioimpact LLC15.12%$177M10.81%Add 27.24%
Lynx1 Capital Management LP13.93%$163M18.86%Not reported
BVF Inc8.94%$105M2.68%Not reported
BlackRock, Inc.8.13%$95.3M0.00%Not reported
State Street Corp5.70%$66.8M0.00%Not reported
Kynam Capital Management, LP4.84%$56.7M3.13%Not reported
Vanguard Capital Management LLC4.06%$47.6M0.00%Not reported
RTW Investments, LP3.67%$43.1M0.37%Add 38.59%
Siren, L.L.C.2.94%$34.5M0.70%Add 58.66%
Geode Capital Management, LLC2.40%$28.2M0.00%Not reported
Blue Owl Capital Holdings LP2.39%$28M4.22%Not reported
Venrock Adviser, LLC2.14%$25.1M0.76%Not reported
Boothbay Fund Management, LLC1.68%$19.7M0.26%Not reported
Dimensional Fund Advisors LP1.63%$19.1M0.00%Not reported
Goldman Sachs Group Inc1.56%$18.2M0.00%Not reported
Affinity Asset Advisors, LLC1.36%$15.9M0.72%Add 12.10%
Vanguard Portfolio Management LLC1.15%$13.5M0.00%Not reported
Boone Capital Management LLC1.09%$12.8M3.00%New Not reported
Elmind Capital, LP1.07%$12.6M3.16%Add 30.19%
Morgan Stanley0.98%$11.5M0.00%Not reported
Twin Focus Capital Partners, LLC0.93%$10.8M1.10%Not reported
AQR Capital Management LLC0.90%$10.6M0.00%Not reported
Northern Trust Corp0.89%$10.4M0.00%Not reported
Bank of America Corp0.79%$9.29M0.00%Not reported
Nuveen, LLC0.73%$8.59M0.00%Not reported
Charles Schwab Investment Management Inc0.72%$8.45M0.00%Not reported
Perceptive Advisors LLC0.66%$7.77M0.12%New Not reported
TCG Crossover Management, LLC0.63%$7.41M0.18%Not reported
Citadel Advisors LLC0.62%$7.24M0.00%Not reported
Deutsche Bank Ag\0.60%$6.97M0.00%Not reported
Vanguard Fiduciary Trust Co0.56%$6.61M0.00%Not reported
Millennium Management LLC0.54%$6.3M0.00%Not reported
Renaissance Technologies LLC0.51%$5.95M0.01%Not reported
Great Point Partners LLC0.47%$5.46M1.03%Not reported
JPMorgan Chase & Co0.44%$5.21M0.00%Not reported
Two Sigma Investments, LP0.42%$4.96M0.00%Not reported
Bleichroeder LP0.39%$4.55M0.81%Add 150.00%
UBS Group AG0.39%$4.53M0.00%Not reported
FMR LLC0.37%$4.37M0.00%Not reported
Adage Capital Partners GP, L.L.C.0.37%$4.33M0.01%New Not reported
Susquehanna Portfolio Strategies, LLC0.36%$4.26M0.07%Not reported
PFM Health Sciences, LP0.30%$3.5M0.30%Reduce 15.38%
Moore Capital Management, LP0.30%$3.46M0.05%Not reported
Bank of New York Mellon Corp0.27%$3.11M0.00%Not reported
Squarepoint Ops LLC0.26%$3.06M0.00%Not reported
Prudential Financial Inc0.26%$3.05M0.00%Not reported
Wellington Management Group LLP0.26%$3M0.00%Add 10.09%
American Century Companies Inc0.24%$2.85M0.00%Not reported
Engineers Gate Manager LP0.24%$2.79M0.04%Not reported
Trexquant Investment LP0.24%$2.77M0.02%Not reported
50 of 172 holders

Activity score

Premium
0
25
50
75
100
WEAK
STRONG
Unlock

AI Activity Analysis

Premium
Coming soonAI reads of insider, institutional and company activity will appear here for Premium accounts.

Historical Activity Patterns

Premium
Historical Activity PatternsHistorical periods where multiple activity categories converged, with subsequent market performance shown for context.Unlock

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.